The Primary Aim of the Workshop is to facilitate the development of multicenter clinical trials related to relapse after both allogeneic and autologous hematopoietic stem cell transplantation (HSCT). Specifically, these trials are intended to:
1. Investigate the biology of relapse;
2. Validate new proposed molecular definitions of relapse;
3. Assess interventions designed to prevent relapse; and
4. Evaluate approaches to treat relapse.
Click here to view the entire NCI at Frederick
If you have any questions or would like to add your own event to the NCI at Frederick calendar,
please contact the Conference Center
at 301-846-5865 or email@example.com.